Product portfolio

Donor Screening

Why donor screening centers turn to Roche

One-third of the blood and plasma donated worldwide in 2015 was screened for infectious diseases using blood safety solutions from Roche.1

For organizations facing the critical challenge of ensuring safe blood supplies, Roche offers a comprehensive screening solution. Pre-analytics and IT, and nucleic acid testing (NAT) are all available from a single source.

 

Keeping the blood supply safe

Blood is a crucial healthcare resource and can save lives. Every year worldwide there are over 164 million blood and plasma donations that are commonly used in supportive care for cardiovascular and transplant surgery patients, trauma victims, and those undergoing cancer therapy.2,3 Ensuring access to a sufficient and safe supply of blood and blood-derived products is an international health priority that has been highlighted by the World Health Organization since 1975.4 Roche is a trusted partner for screening centers.

 

One blood donation has the potential to save 3 lives5

Blood transfusion safety relies heavily on the accurate and timely screening of blood for transmissible infections. In addition, pathogens evolve and new ones emerge, demanding the need for continuous and robust test innovation and development.

With over 30 years in blood safety, Roche offers the most comprehensive screening solution on the market today.6 Roche has become a trusted partner for screening centers, and is the only single provider for Nucleic Acid Testing (NAT), Lab Automation and IT for blood centers and blood fractionators worldwide.6

donor-screening-NAT
Donor Screening - Nucleic Acid Testing

 

Explore our commitment to developing assays, instruments and automation that deliver safety and efficiency.

 

Learn more

donor-screening-lab-auto
Donor Screening - Personalized Lab Automation

 

Simplify operations, reduce manual tasks and increase both efficiency and quality with automation solutions for labs of all sizes.

 

Learn more

Achieve the maximum efficiency that only Roche can offer. Each Roche solution works together throughout every step of your blood screening workflow, including pre-analytics, and nucleic acid testing. 

 

The IT solutions intelligently link every part of your workflow, from routing samples and dynamically monitoring production, to making it simple to adjust workflows for maximum productivity.

 

 
Do you have any questions?
Contact Us

References

  1. World Health Organization (WHO). Blood safety and availability. http://www.who.int/mediacentre/factsheets/fs279/en/. Accessed January 24, 2017.
  2. World Health Organization. Blood Safety and Availability 2017. Retrieved 18 June 2018 from: www.who.int/en/news-room/fact-sheets/detail/blood-safety-and-availability
  3. Plasma Protein Therapeutics Association 2017. Retrieved 18 June 2018 from: http://www.pptaglobal.org/images/Data/Plasma_Collection/Total_Yearly_Collections_2007_-_2016.pdf
  4. World Health Organization. Global Status Report on Blood Safety and Availability 2016.
  5. American Red Cross Blood Services. Retrieved on 18 June 2018 from: https://www.redcrossblood.org/donate-blood/how-to-donate/how-blood-donations-help/blood-needs-blood-supply.html
  6. Data on file. Roche Diagnostics International Ltd.
Filter